Consistent with Figure 3E, mice vaccinated with PancVAX2 displayed a significant increase in CD137+CD8+ T cells within the tumor after vaccination compared with mice receiving the CD8 vaccine (Figure 4B). This evidence concerns the gene TNFRSF9 and neoplasm.